Caidya is a global clinical research organization (CRO) established in 2022, born from the merger of Clintrax Global, a leader in clinical trial site contracting and regulatory services, and the eClinical Solutions business of Bioclinica, known for its technology platforms (EDC, CTMS, IRT, ePRO, Imaging). Owned by private equity firm Welsh, Carson, Anderson & Stowe (WCAS), Caidya provides comprehensive, technology-enabled clinical trial solutions to pharmaceutical, biotechnology, and medical device companies worldwide. Their services span the clinical development lifecycle, focusing on site activation, patient engagement, data management, biostatistics, regulatory affairs, and leveraging advanced eClinical technologies to streamline trials and improve outcomes.
Serves as the central hub for executive leadership, strategic planning, corporate administration (finance, HR, legal), global operations management, and business development.
Located within a modern office park in the Research Triangle Park area, offering facilities designed for collaboration and supporting global operations.
Likely fosters a dynamic, integrated culture focused on client service, technological innovation, operational efficiency, and scientific rigor, reflecting the combination of its heritage companies.
Represents the unified strategic center of the merged entities, driving Caidya's global strategy and connecting its worldwide operations and service delivery network.
Caidya operates globally, supporting clinical trials across North America, Europe, Asia-Pacific, and other regions. Its worldwide functions include clinical operations (monitoring, project management), site identification, activation and contracting, patient recruitment and retention services, regulatory affairs and submissions, comprehensive data management, biostatistics, medical writing, pharmacovigilance, and the deployment and support of a full suite of eClinical technologies (EDC, IRT, CTMS, ePRO/eCOA, Safety Systems, Medical Imaging).
4820 Emperor Blvd, Suite 400
Durham
NC
USA
Address: 100 Overlook Center, Suite 101, Princeton, NJ 08540
Supports the dense concentration of pharmaceutical and biotechnology companies in the US Northeast corridor.
Address: Building 3, Chiswick Park, 566 Chiswick High Road, London, W4 5YA
Provides strategic access and support for clinical trials conducted within the European region.
Address: Embassy Tech Square, Marathahalli Outer Ring Road, Kadubeesanahalli Village, Varthur Hobli, Bangalore 560103
Leverages India's skilled talent pool to provide efficient and scalable support for global clinical development programs.
Address: Shinagawa Seaside TS Tower 12F, 4-12-3 Higashi-Shinagawa, Shinagawa-ku, Tokyo 140-0002
Provides localized expertise and support for navigating Japan's clinical research environment.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Caidya' leadership includes:
Caidya has been backed by several prominent investors over the years, including:
In the past year, Caidya has continued to solidify its leadership team following its formation. Notable activity includes key appointments aimed at strengthening commercial and operational capabilities. Publicly announced C-suite changes appear minimal, suggesting stability in the core executive team. (Based on available public information as of early 2024).
Discover the tools Caidya uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Caidya most likely utilizes a standardized email format for professional communication, commonly based on employee names.
[first].[last]@caidya.com
Format
jane.doe@caidya.com
Example
85%
Success rate
Caidya Website / PR Newswire • February 20, 2024
Caidya announced its participation and presentations at the SCOPE Summit 2024, highlighting expertise in areas like patient diversity, decentralized trials, and AI in clinical research through various sessions led by its executives....more
Business Wire • October 26, 2023
Clario, a healthcare research technology company, and Caidya formed a strategic partnership to integrate Clario's endpoint data collection solutions with Caidya's comprehensive CRO services, aiming to streamline clinical trial processes for sponsors....more
Caidya Website / PR Newswire • April 11, 2023
Caidya announced the appointment of Jamie Toth as its new Chief Commercial Officer, bringing extensive experience in the CRO and life sciences industry to lead the company's global commercial strategy....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Caidya, are just a search away.